Amoxicillin + Clavulanic Acid
No
No
Standard Drug List
Active ingredients: Amoxicillin | Clavulanic Acid Synonym: Co-amoxiclav
General information
Subsidy Information and Financing Scheme
[SDL] Amoxicillin & Clavulanic Acid Injection, Amoxicillin 500 mg + Clavulanic Acid 100 mg, Amoxicllin 1 g + Clavulanic Acid 200 mg
[SDL] Amoxicillin & Clavulanic Acid Oral Suspension, Amoxicillin 200 mg/5 mL + Clavulanic Acid 28.5 mg/5 mL, Amoxicillin 600 mg/5 mL + Clavulanic Acid 42.9 mg/5 mL
[SDL] Amoxicillin & Clavulanic Acid Tablet, Amoxicillin 500 mg + Clavulanic Acid 125 mg, Amoxicillin 875 mg + Clavulanic Acid 125 mg
Drug Guidance for Subsidy
Not Applicable
General Availability in Public Healthcare Institution
Note:
General availability information reflected is based on the Public Healthcare Institutions’ (PHI) formulary on what is commonly used for treating their patient population and may or may not be available for patients not under the care of that institution. It does not reflect the PHI’s actual inventory availability and is subjected to change. Please consult the Public Hospitals or Polyclinics for details on availability and supply restrictions/considerations. General availability is not tied to any brand unless otherwise stated.
Users are to consult the respective PHIs for actual inventory availability and supply restrictions/consideration
Availability information
Formulation | Public Healthcare Institution |
|---|---|
Injection, Amoxicllin 1 g + Clavulanic Acid 200 mg |
|
Oral Suspension, Amoxicillin 200 mg/5 mL + Clavulanic Acid 28.5 mg/5 mL |
|
Oral Suspension, Amoxicillin 600 mg/5 mL + Clavulanic Acid 42.9 mg/5 mL |
|
Tablet, Amoxicillin 500 mg + Clavulanic Acid 125 mg |
|
Tablet, Amoxicillin 875 mg + Clavulanic Acid 125 mg |
|
Registered Product(s) Information
Clinical and product info
Clinical info | Product Info |
|---|---|
Information under the Indication, Dosage and Contraindication sections are extracted from the relevant Package Insert/Patient Information Leaflet of the product available on HSA Infosearch. For more information, please refer to the product's Package Insert/ Patient Information Leaflet available on HSA Infosearch. The information provided is for informational purposes only, and is not exhaustive. The information provided is not a substitute for professional medical advice. Please consult a qualified healthcare provider for any medical advice. | Information available here are product details as registered with the HSA. As this website is updated monthly, please refer to HSA Infosearch for the most updated product information. |
Oral
MOXICLAV BIS DRY POWDER FOR ORAL SUSPENSION 457MG/5ML [SIN16453P]*
MOXICLAV DRY POWDER FOR ORAL SUSPENSION 156.25 MG/5 ML [SIN10690P]
MOXICLAV FORTE DRY POWDER FOR ORAL SUSPENSION 312.5 MG/5 ML [SIN10687P]
* Clinical information is available for this product.
Intravenous
CURAM 1000MG+200MG POWDER FOR INTRAVENOUS SOLUTION [SIN13390P]*
MOXICLAV POWDER FOR SOLUTION FOR INJECTION/ INFUSION 1.2G/VIAL [SIN17446P]*
SALACLAV POWDER FOR SOLUTION FOR INJECTION 1.2G/VIAL [SIN15043P]*
* Clinical information is available for this product.
